Pneumoconiosis (CA60): Complete ICD-11 Coding Guide

1. Introduction

Pneumoconiosis represents a set of occupational lung diseases caused by chronic inhalation and accumulation of microparticles in the lungs, resulting in progressive interstitial fibrosis. This condition, historically associated with industrial and mining activities, remains a significant cause of respiratory morbidity in workers exposed to environments with mineral, metallic, or synthetic dust.

From a histopathological perspective, pneumoconioses are characterized by the deposition of inhaled particles in the lung parenchyma, triggering a chronic inflammatory response that culminates in interstitial fibrosis. The severity of the disease correlates with the nature of the inhaled particles, the intensity and duration of exposure, as well as individual factors such as genetic predisposition and concomitant smoking.

The clinical importance of pneumoconioses transcends individual impact, representing a significant public health and occupational health problem. Although workplace safety regulations have reduced incidence in countries with strict legislation, millions of workers worldwide remain exposed to risk conditions, especially in extractive industries, civil construction, ceramic manufacturing, and mineral processing.

Precise coding of pneumoconiosis in the ICD-11 system is fundamental for epidemiological surveillance, recognition of occupational diseases, planning of preventive policies, ensuring workers' rights and compensation, and facilitating research on the efficacy of protection measures. Correct classification allows identification of exposure patterns, evaluation of the effectiveness of occupational health programs, and directing resources toward appropriate prevention and treatment.

2. Correct ICD-11 Code

Code: CA60

Description: Pneumoconiosis

Parent category: Lung diseases due to external agents

Official definition: Pneumoconiosis is a lung disease caused by inhalation of microparticles and characterized from a histopathological standpoint by interstitial fibrosis. The different types of pneumoconiosis vary in relation to the types of inhaled particles, frequently associated with some occupational exposure.

This code encompasses the complete spectrum of fibrotic lung diseases caused by inhalation of inorganic particles, including silicosis, asbestosis, coal worker's pneumoconiosis, berylliosis, siderosis, stannosis, baritosis, and other less common forms. The ICD-11 classification organizes these conditions under the main code CA60, with specific subcategories for each type of pneumoconiosis based on the causative agent.

The hierarchical structure of the code allows both generic coding when the specific type of pneumoconiosis is not clearly identified, and detailed coding when the etiological agent is known. This flexibility is particularly useful in situations where multiple occupational exposures have occurred or when etiological investigation is incomplete, maintaining diagnostic accuracy without compromising clinical documentation.

3. When to Use This Code

The CA60 code should be used in specific clinical situations where there is confirmation of fibrosing lung disease related to occupational inhalation of inorganic microparticles:

Scenario 1: Mining worker with confirmed silicosis A worker with 25 years of activity in underground mines presents with progressive dyspnea, chronic cough, and chest radiography demonstrating nodular opacities predominantly in the upper fields. High-resolution computed tomography confirms centrilobular nodules and fibrotic conglomerates. Occupational history documents prolonged exposure to crystalline silica. This case requires coding with CA60, specifically the subcategory for silicosis.

Scenario 2: Construction worker with asbestosis Patient with a history of 30 years working with thermal insulation and asbestos removal develops dyspnea on moderate exertion. Complementary examinations reveal bilateral reticular pattern in the lung bases, pleural thickening, and restriction on spirometry. Pulmonary biopsy, when performed, identifies asbestos bodies and interstitial fibrosis. Appropriate coding uses CA60 with specification for asbestosis.

Scenario 3: Sandblasting worker with accelerated pneumoconiosis Young worker involved in sandblasting without adequate protection for 5 years develops rapidly progressive respiratory symptoms. Images show progressive massive fibrosis with extensive conglomerates. The history of intense silica exposure over a short period characterizes the accelerated form of the disease. CA60 is the correct code, documenting the severity and accelerated progression.

Scenario 4: Foundry worker with siderosis Welder with chronic exposure to metal fumes containing iron oxide presents with radiological changes showing diffuse opacities but maintains relatively preserved pulmonary function. Siderosis, a generally benign form of pneumoconiosis, requires CA60 coding with specification of the agent (iron), even when there is no significant functional impairment.

Scenario 5: Aerospace worker with berylliosis Technician involved in the manufacture of aerospace components with exposure to beryllium develops chronic granulomatous lung disease. The beryllium lymphocyte proliferation test is positive, and biopsy confirms non-caseating granulomas. This specific form of pneumoconiosis, with particular immunological characteristics, is coded under CA60.

Scenario 6: Mixed exposure in ceramic industry Worker in the ceramic industry with simultaneous exposure to silica, kaolin, and other silicates develops interstitial lung disease. When it is not possible to determine the predominant agent, the generic CA60 code can be used, documenting the occupational nature and mixed exposure.

4. When NOT to Use This Code

The CA60 code should not be applied in various situations that may initially appear similar but represent distinct clinical entities:

Lung diseases from organic dusts: Conditions such as hypersensitivity pneumonitis (farmer's lung, bird breeder's lung, bagassosis) result from inhalation of organic dusts and have a different immunological mechanism. These conditions are coded under CA80 (Airway diseases due to specific organic dusts) and not CA60, as they involve hypersensitivity reaction rather than fibrosis from inorganic particle deposition.

Acute chemical inhalation injuries: Acute exposures to toxic gases, chemical vapors, or fumes that cause acute chemical pneumonitis, pulmonary edema, or reactive airway dysfunction syndrome should be coded under CA81 (Respiratory conditions due to inhalation of chemicals, gases, fumes, or vapors). The fundamental differentiation lies in the acute nature of exposure and the absence of chronic interstitial fibrosis characteristic of pneumoconioses.

Idiopathic pulmonary fibrosis: When interstitial fibrosis occurs without documented history of occupational exposure to inorganic particles and after exclusion of other known causes, the condition should be classified as idiopathic interstitial lung disease, not as pneumoconiosis.

Chronic pulmonary infections: Tuberculosis, histoplasmosis, and other infections that cause secondary pulmonary fibrosis should not be coded as pneumoconiosis, even in workers with occupational dust exposure, unless there is clear evidence of pneumoconiosis contribution as a coexisting condition.

Pulmonary neoplasms: Although workers with pneumoconiosis, especially asbestosis and silicosis, have increased risk for lung cancer and mesothelioma, these neoplasms have their own specific codes. Pneumoconiosis may be coded as a coexisting condition but does not replace appropriate oncological coding.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

The diagnosis of pneumoconiosis requires integration of multiple clinical, radiological, functional, and occupational elements. First, establish a detailed occupational history documenting: type of work activity, duration of exposure, nature of inhaled particles, use of personal protective equipment, and environmental conditions of the workplace.

Clinical evaluation should identify characteristic respiratory symptoms such as progressive dyspnea, chronic cough (initially dry, later productive), wheezing, and functional limitation. Physical examination may reveal crackles, especially at lung bases, although it may be normal in early stages.

Imaging studies are fundamental: chest radiography using the standardized classification of the International Labour Organization allows staging and objective documentation. High-resolution computed tomography offers superior sensitivity, identifying early changes and characterizing specific patterns of each type of pneumoconiosis.

Pulmonary function tests generally demonstrate a restrictive pattern with reduction in vital capacity and total lung capacity, in addition to decreased carbon monoxide diffusing capacity. In some cases, especially when there is an associated obstructive component, a mixed pattern may occur.

Step 2: Verify specifiers

After confirming the diagnosis of pneumoconiosis, determine the specific type based on the causative agent: silicosis (exposure to crystalline silica), asbestosis (exposure to asbestos fibers), coal workers' pneumoconiosis, berylliosis, or other less common forms.

Assess disease severity considering radiological extent, functional impairment, clinical symptoms, and impact on daily activities. Classify as simple or complicated (with progressive massive fibrosis), and document progression as chronic, accelerated, or acute, as applicable.

Identify associated complications such as tuberculosis (especially in silicosis), lung neoplasms, pulmonary hypertension, cor pulmonale, spontaneous pneumothorax, or recurrent respiratory infections. These complications may require additional coding.

Document aggravating factors such as concomitant smoking, which potentiates the deleterious effects of occupational exposure and accelerates disease progression, particularly in asbestosis and silicosis.

Step 3: Differentiate from other codes

Pneumonitis: Differs from pneumoconiosis by representing acute or subacute inflammation of the lung parenchyma, generally with faster progression and potential for reversibility. Pneumonitis may be caused by infections, medication reactions, or hypersensitivity, whereas pneumoconiosis is characterized by irreversible progressive chronic fibrosis related to deposition of inorganic particles.

CA80 - Diseases of the airways due to specific organic dusts: This category encompasses conditions such as hypersensitivity pneumonitis and extrinsic allergic alveolitis, caused by inhalation of organic antigens (fungal spores, animal proteins, thermophilic bacteria). The pathogenic mechanism is immunological (hypersensitivity reaction types III and IV), different from the fibrotic response to inorganic particles in pneumoconiosis. Clinically, diseases from organic dusts frequently present recurrent acute episodes related to exposure, with potential for reversibility if exposure ceases early.

CA81 - Respiratory conditions due to inhalation of chemical substances, gases, fumes, or vapors: This code applies to acute or subacute lung injuries caused by inhalation of chemical irritants, such as chemical pneumonitis, toxic pulmonary edema, post-inhalation obliterative bronchiolitis, or reactive airway dysfunction syndrome. The fundamental distinction lies in the chemical (non-particulate) nature of the agent, the generally acute pattern of exposure, and the absence of chronic interstitial fibrosis typical of pneumoconioses.

Step 4: Necessary documentation

For adequate coding of pneumoconiosis, medical documentation must include:

Complete occupational history: Occupations held with dates, detailed description of activities, materials handled, environmental conditions, protective measures used, and total duration of exposure.

Clinical manifestations: Respiratory symptoms with chronology of onset and progression, functional limitations, relevant comorbidities, and detailed smoking history.

Results of complementary examinations: Reports of chest radiography with standardized classification, computed tomography with description of alteration patterns, complete spirometry with absolute and predicted percentage values, diffusion test, and when available, results of lung biopsy.

Assessment of causal nexus: Clear documentation establishing relationship between occupational exposure and lung disease, considering adequate latency, compatibility of radiological pattern with the suspected agent, and exclusion of other causes.

6. Complete Practical Example

Clinical Case:

A 58-year-old male patient presents with progressive dyspnea on exertion for 3 years, initially with strenuous activity, currently limiting moderate daily activities. Reports persistent dry cough and episodes of chest wheezing. Denies fever, weight loss, or hemoptysis.

Occupational history reveals 32 years working in an underground gold mine, performing rock drilling and blasting operations. Reports that use of protective masks was irregular during the first 15 years of work, becoming more consistent thereafter following implementation of an occupational safety program. Former smoker with a 20 pack-year smoking history, smoking cessation 10 years ago.

On physical examination, patient is in good general condition, respiratory rate of 18 breaths per minute at rest, oxygen saturation of 94% on room air. Pulmonary auscultation reveals fine bibasal crackles. Cardiovascular examination without significant abnormalities.

Chest radiograph demonstrates multiple small nodular opacities (2-4mm) distributed predominantly in the upper and middle lung fields, classified as profusion 2/2 by the International Labour Organization classification, with presence of conglomerates at the apices bilaterally, characterizing progressive massive fibrosis.

High-resolution computed tomography confirms diffuse centrilobular and subpleural nodules, fibrotic conglomerates in the upper lobes with architectural distortion, interlobular septal thickening, and areas of paracicatricial emphysema. Absence of pleural effusion or significant mediastinal lymphadenopathy.

Spirometry reveals a mixed pattern with reduced forced vital capacity (FVC 62% of predicted), forced expiratory volume in the first second (FEV1 58% of predicted), and FEV1/FVC ratio of 0.68. Carbon monoxide diffusion test demonstrates significant reduction (48% of predicted).

Step-by-Step Coding:

Criteria analysis: The patient meets diagnostic criteria for pneumoconiosis based on: (1) documented occupational history of prolonged exposure to crystalline silica in mining; (2) progressive respiratory symptoms compatible with the disease; (3) characteristic radiological findings of silicosis with progressive massive fibrosis; (4) mixed restrictive-obstructive functional impairment with reduced diffusion; (5) exclusion of other causes of interstitial lung disease.

Code selected: CA60 (with specific subcode for silicosis, if available in the documentation system used)

Complete justification: Silicosis represents the most common form of pneumoconiosis in mining workers exposed to crystalline silica. The radiological pattern with predominantly upper nodules and fibrotic conglomerates is pathognomonic. The latency of approximately 29 years (considering symptom onset 3 years before consultation and 32 years of exposure) is compatible with chronic silicosis. The presence of progressive massive fibrosis indicates complicated form of the disease. The obstructive component on spirometry may reflect both paracicatricial emphysema and previous smoking history.

Applicable complementary codes: Consider additional coding for chronic respiratory insufficiency if persistent hypoxemia is documented, and for smoking history as a contributing factor. If there is evidence of pulmonary hypertension or cor pulmonale on subsequent evaluations, these should also be coded separately.

7. Related Codes and Differentiation

Within the Same Category:

Pneumonitis vs. CA60: Pneumonitis refers to acute or subacute inflammation of the lung parenchyma, while CA60 (pneumoconiosis) is characterized by progressive chronic interstitial fibrosis. Use pneumonitis for acute inflammatory processes with potential for reversibility (radiation pneumonitis, drug-induced pneumonitis, infectious pneumonitis). Use CA60 when there is documentation of chronic occupational exposure to inorganic particles and evidence of permanent fibrosis. Temporal distinction is fundamental: pneumonitis develops over days to weeks, pneumoconiosis requires years of exposure.

CA80 - Airway diseases due to specific organic dusts vs. CA60: CA80 applies when the causative agent is organic dust (spores, proteins, bacteria) and the mechanism is immunologic (hypersensitivity). Examples include farmer's lung (exposure to moldy hay), bird breeder's lung (exposure to avian proteins), and bagassosis (exposure to sugarcane bagasse). Use CA60 for inorganic particles (silica, asbestos, coal, metals) with a mechanism of direct fibrosis. Clinically, CA80 frequently presents with recurrent acute episodes related to reexposure, while CA60 is characterized by continuous insidious progression.

CA81 - Respiratory conditions due to inhalation of chemicals, gases, fumes, or vapors vs. CA60: CA81 is used for lung injuries caused by inhalation of gaseous or vaporized chemical agents, not particulate. It includes acute chemical pneumonitis, toxic pulmonary edema, obliterative bronchiolitis, and reactive airway dysfunction syndrome. Exposure is usually acute or subacute, with rapid-onset clinical manifestations. Use CA60 for chronic exposures to inorganic solid particles with development of fibrosis over years. The physical nature of the agent (particulate vs. gaseous) and the temporal pattern of exposure are key differentiating elements.

Differential Diagnoses:

Idiopathic pulmonary fibrosis may mimic pneumoconiosis radiologically, but occurs without identifiable occupational exposure. Sarcoidosis presents with non-caseating granulomas and may affect workers exposed to particles, but has systemic features and a distinct peribronchvascular lymphatic distribution pattern. Chronic hypersensitivity pneumonitis may be confused with pneumoconiosis, but the history of exposure to organic antigens and the tomographic pattern with ground-glass opacities and air trapping aid in differentiation. Pulmonary tuberculosis, especially fibrocavitary forms, may coexist with silicosis, requiring careful microbiological investigation.

8. Differences with ICD-10

In the ICD-10 classification, pneumoconioses were coded in category J60-J65, with specific codes for different types: J60 (Pneumoconiosis of coal workers), J61 (Pneumoconiosis due to asbestos and other mineral fibers), J62 (Pneumoconiosis due to silica dust), J63 (Pneumoconiosis due to other inorganic dusts), and J64 (Unspecified pneumoconiosis).

The transition to ICD-11 with code CA60 represents a significant conceptual reorganization. The hierarchical structure of ICD-11 groups all pneumoconioses under a single main code (CA60), with specific subcategories for each etiological agent, rather than independent codes as in ICD-10. This approach facilitates identification of the disease group while maintaining etiological specificity.

Another important change is the emphasis on histopathological characterization (interstitial fibrosis) and the mechanism of particle deposition in the official ICD-11 definition, providing greater conceptual clarity. ICD-11 also offers greater flexibility for coding mixed exposures and unspecified forms, recognizing the clinical reality of occupational environments with multiple simultaneous exposures.

The practical impact of these changes includes the need to update health information systems, train coders, and review epidemiological surveillance protocols. For occupational health professionals, the new structure can facilitate comparative analyses between different types of pneumoconioses and improve tracking of temporal trends related to changes in industrial practices and safety regulations.

9. Frequently Asked Questions

How is pneumoconiosis diagnosed? The diagnosis of pneumoconiosis requires a multifaceted approach integrating detailed occupational history, clinical manifestations, imaging studies, and pulmonary function tests. Occupational history is fundamental, documenting type of activity, duration of exposure, and nature of inhaled particles. Chest radiography using standardized classification allows identification and staging of changes, while high-resolution computed tomography offers greater sensitivity for early detection and characterization of specific patterns. Pulmonary function tests assess the degree of functional impairment. Lung biopsy is rarely necessary, being reserved for atypical cases or when there is significant diagnostic uncertainty.

Is treatment available in public health systems? Pneumoconioses are occupational diseases recognized worldwide, and most public health systems offer medical follow-up for affected workers. Treatment is primarily supportive, focusing on prevention of progression through cessation of exposure, management of complications, and pulmonary rehabilitation. Bronchodilator medications and home oxygen therapy are provided when indicated. Vaccination against influenza and pneumococcus is recommended. In advanced cases with severe respiratory insufficiency, lung transplantation may be considered in specialized centers. Occupational health surveillance programs typically cover periodic examinations and longitudinal follow-up.

How long does treatment last? Pneumoconiosis is an irreversible chronic condition requiring continuous medical follow-up throughout life. There is no curative treatment that reverses established fibrosis. Management is permanent, with regular consultations for monitoring disease progression, periodic functional evaluation, and adjustment of supportive therapies as needed. The frequency of follow-up varies according to severity: mild cases may be evaluated annually, while advanced or progressive forms require more frequent consultations, quarterly or semiannually. Even after cessation of occupational exposure, the disease may continue to progress, especially in silicosis and asbestosis, necessitating continuous surveillance.

Can this code be used in medical certificates? Yes, the code CA60 can and should be used in medical certificates when the diagnosis of pneumoconiosis is established. For documentation of work absence, it is important to specify the type of pneumoconiosis and the severity of functional impairment. In occupational health contexts, proper coding is essential for recognition of the disease as work-related, ensuring labor and social security rights. Certificates for compensation or disability retirement purposes frequently require detailed documentation including occupational history, complementary examinations, and assessment of work disability. It is recommended to include both the ICD code and a clear textual description of the diagnosis.

Does pneumoconiosis always cause symptoms? Not necessarily. Early stages of pneumoconiosis, especially simple forms, may be asymptomatic and detected only on radiological examinations during occupational screening. Symptoms generally develop gradually as fibrosis progresses and functional impairment increases. Some forms of pneumoconiosis, such as siderosis (iron deposition), may cause significant radiological changes with minimal or no functional impairment. However, complicated forms with progressive massive fibrosis invariably cause significant symptoms, including progressive dyspnea, functional limitation, and complications such as respiratory insufficiency and pulmonary hypertension.

Is there effective prevention for pneumoconiosis? Yes, pneumoconiosis is an essentially preventable disease through occupational exposure control measures. Primary prevention includes engineering controls (adequate ventilation, process humidification, dust source enclosure), substitution of materials with less harmful alternatives when possible, and correct and consistent use of respiratory personal protective equipment. Periodic medical surveillance of exposed workers allows early detection and intervention before serious impairment. Occupational health education, training on risks, and rigorous implementation of safety regulations are fundamental. Smoking cessation is an important additional preventive measure, as tobacco potentiates the deleterious effects of occupational exposure.

Does pneumoconiosis increase the risk of lung cancer? Yes, some forms of pneumoconiosis are associated with increased risk of pulmonary and pleural neoplasms. Asbestosis has a well-established association with bronchogenic carcinoma and pleural mesothelioma, with risk proportional to the intensity and duration of exposure. Silicosis is also associated with increased risk of lung cancer, independent of smoking. The combination of pneumoconiosis and smoking has a synergistic effect, significantly multiplying the risk of cancer. Workers with pneumoconiosis should receive counseling about this increased risk, encouragement for smoking cessation, and in some contexts may be candidates for lung cancer screening programs with low-dose computed tomography, according to local protocols.

Is it possible to work with a diagnosis of pneumoconiosis? The ability to continue working depends on the severity of pneumoconiosis, the degree of functional impairment, and the nature of the work. In early stages with preserved pulmonary function, work in activities without additional dust exposure may be feasible. However, it is essential to completely cease exposure to the causative agent to prevent progression. Workers should be relocated to functions without exposure to inhalable particles. In advanced cases with significant functional impairment, limiting dyspnea, or need for oxygen therapy, permanent work absence is generally necessary. Individual assessment by a specialist physician in pulmonology or occupational medicine, considering pulmonary function, functional capacity, and specific occupational demands, guides decisions regarding work fitness.

Conclusion:

Proper coding of pneumoconiosis with the ICD-11 code CA60 is fundamental for recognition, documentation, and appropriate management of these important occupational diseases. Understanding diagnostic criteria, differentiating from similar conditions, and properly documenting the relationship between occupational exposure and pulmonary disease are essential skills for health professionals involved in the care of exposed workers. Prevention remains the most effective strategy, highlighting the importance of occupational health surveillance and rigorous implementation of protective measures in work environments.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Pneumoconiosis

Partager